American Water Works Company Inc
Change company Symbol lookup
Select an option...
AWK American Water Works Company Inc
ASO Academy Sports and Outdoors Inc
GAB Gabelli Equity Trust
STRC Sarcos Technology and Robotics Corp
RLMD Relmada Therapeutics Inc
LMND Lemonade Inc
NAACW North Atlantic Acquisition Equity Warrant Exp 20 Oct 2025 *W EXP 10/20/2025
CG Carlyle Group Inc
ETR Entergy Corp
SKIN Beauty Health Co
Go

Utilities : Water Utilities | Mid Cap Blend
Company profile

American Water Works Company, Inc. is a water and wastewater utility company. The Company's business segment, Regulated Businesses, involves the ownership of utilities that provide water and wastewater services to residential, commercial, industrial, public authority, fire service and sales for resale customers. It also provides regulated-like services through its Military Services Group (MSG), which enters into long-term contracts with the United States government to provide water and wastewater services on various military installations. It also has five contracts with municipal customers to operate and manage water and wastewater facilities and provide other related services through its Contract Services Group (CSG). It operates other market-based businesses that provide water and wastewater services to the United States government on military installations, as well as municipalities and utility customers. Its portfolio also includes City of Villa Grove water and wastewater systems.

Closing Price
$134.71
Day's Change
-2.62 (-1.91%)
Bid
--
Ask
--
B/A Size
--
Day's High
139.05
Day's Low
133.67
Volume
(Below Average)
Volume:
691,710

10-day average volume:
782,782
691,710

Cowen reiterates outperform on Curaleaf after stronger-than-expected results

7:28 am ET August 9, 2022 (MarketWatch)
Print

Cowen analyst Vivien Azer on Tuesday reiterated her outperform rating on Curaleaf Holdings Inc. and trimmed her 2023 revenue estimate to $1.64 billion from $1.65 billion based on the cannabis company's shift away from its lower margin wholesale business. Curaleaf's 8% growth in sales over the previous quarter beat Cowen's forecast of 2%. Gross margin was 250 basis points above Cowen's projection of 52% and adjusted Ebitda of 25.5% beat Cowen's estimate by 220 basis points. Shares of Curaleaf are down 36.8% this year, compared to a loss of 53.7% by the AdvisorShares Pure US Cannabis ETF (MSOS) and 19.2% loss by the Nasdaq .

-Steve Gelsi

	

(END) Dow Jones Newswires

August 09, 2022 07:28 ET (11:28 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.